Market Overview:
The global companion animal drugs market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for pet food and rising awareness about pet health and hygiene. In addition, the increasing prevalence of zoonotic diseases is also contributing to the growth of this market. The global companion animal drugs market is segmented on the basis of type, application, and region. On the basis of type, it is divided into antibiotics and antimicrobials, parasiticides, and others. The antibiotics and antimicrobials segment accounted for majority share in 2017 owing to high prevalence of bacterial infections in animals. On the basis of application, it is classified into dogs, cats horses,,and others segments . Dogs accounted for majority share in 2017 owing to high ownership rates across all regions studied .Geographically ,the global companion animal drugs marketis segmentedinto North America , Latin America Europe Asia Pacificand Middle East & Africa .
Product Definition:
A Companion Animal Drug is a drug prescribed for the care and treatment of companion animals. These drugs are important because they help to keep pets healthy and happy. They can also help to improve the quality of life for both pets and their owners.
Antibiotics and Antimicrobials:
Antibiotics and antimicrobials are types of drugs used to treat bacterial infections. The global antibiotics and antimicrobials market is expected to grow at a significant rate owing to the increasing prevalence of bacterial infections in animals. According to the Centers for Disease Control & Prevention (CDC), around 2 million people get infected with antibiotic-resistant bacteria every year in U.
Parasiticides:
Parasiticides are used to eliminate or reduce the population of parasites in an animal. It is also known as anti-parasite drug. There are different types of parasiticides available in the market, which work on different life stages of parasites. Some parasiticides can control various diseases caused by intestinal roundworm and hookworms among others while some can be used for treatment and prevention purpose against tapeworms, fleas, etc.
Application Insights:
The dogs application segment led the global companion animal drugs market in 2017. The segment is expected to witness significant growth over the forecast period owing to rising pet adoption and a growing number of dog-related activities such as grooming, walking and playing. Moreover, increasing spending on veterinary medicines by pet owners for treating diseases in dogs will boost industry growth during the forecast period.
The cats application segment accounted for a considerable share of the overall revenue in 2017 due to high product demand owing to their unique characteristics that make them susceptible to different types of infections and diseases. For instance, feline asthma is an inflammation of lungs caused due largely if not entirely lack of knowledge about cat health issues among its owners coupled with improper hygiene practices leading towards increased prevalence rate which has resulted in increased demand for cat healthcare products globally over recent years.
Regional Analysis:
North America accounted for the largest share of more than 35.0% in 2017 owing to high pet ownership and awareness about animal health among people. The region is expected to maintain its lead throughout the forecast period due to increasing R&D activities by key companies for development of new drugs and rising pet adoption in countries, such as Canada, Mexico, U.S., and Brazil among others.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to growing economy coupled with rising disposable income especially in developing countries like India and China which are majorly supported by government initiatives encouraging people towards companion animals rather than working dogs thus creating a positive impact on overall economy leading into economic growth promoting foreign investments along with trade relations between various economies thereby boosting market demand across this region during the forecast period from 2018 To 2030 (estimated).
Growth Factors:
- Increasing demand for companion animals from developed countries
- Rising disposable income of people in developing countries
- Growing awareness about the benefits of companion animals among people
- Proliferation of pet-friendly policies by governments and private organizations
- Technological advancements in the field of veterinary drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Companion Animal Drugs Market Research Report
By Type
Antibiotics and Antimicrobials, Parasiticides, Others
By Application
Dogs, Cats, Horses, Others
By Companies
Zoetis, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Vetoquinol, Virbac, Dechra Pharmaceuticals, Ceva Sante Animale, Aratana Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Companion Animal Drugs Market Report Segments:
The global Companion Animal Drugs market is segmented on the basis of:
Types
Antibiotics and Antimicrobials, Parasiticides, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs, Cats, Horses, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Bayer
- Boehringer Ingelheim
- Eli Lilly
- Merck
- Vetoquinol
- Virbac
- Dechra Pharmaceuticals
- Ceva Sante Animale
- Aratana Therapeutics
Highlights of The Companion Animal Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics and Antimicrobials
- Parasiticides
- Others
- By Application:
- Dogs
- Cats
- Horses
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Companion Animal Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Companion Animal Drugs are medications specifically designed for use in animals. They are often prescribed to treat specific medical conditions or injuries in companion animals, such as dogs and cats.
Some of the major companies in the companion animal drugs market are Zoetis, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Vetoquinol, Virbac, Dechra Pharmaceuticals, Ceva Sante Animale, Aratana Therapeutics.
The companion animal drugs market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Companion Animal Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Companion Animal Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Companion Animal Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Companion Animal Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Companion Animal Drugs Market Size & Forecast, 2020-2028
4.5.1 Companion Animal Drugs Market Size and Y-o-Y Growth
4.5.2 Companion Animal Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics and Antimicrobials
5.2.2 Parasiticides
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Dogs
6.2.2 Cats
6.2.3 Horses
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Companion Animal Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Companion Animal Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics and Antimicrobials
9.6.2 Parasiticides
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Dogs
9.10.2 Cats
9.10.3 Horses
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics and Antimicrobials
10.6.2 Parasiticides
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Dogs
10.10.2 Cats
10.10.3 Horses
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics and Antimicrobials
11.6.2 Parasiticides
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Dogs
11.10.2 Cats
11.10.3 Horses
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics and Antimicrobials
12.6.2 Parasiticides
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Dogs
12.10.2 Cats
12.10.3 Horses
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics and Antimicrobials
13.6.2 Parasiticides
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Dogs
13.10.2 Cats
13.10.3 Horses
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Companion Animal Drugs Market: Competitive Dashboard
14.2 Global Companion Animal Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Bayer
14.3.3 Boehringer Ingelheim
14.3.4 Eli Lilly
14.3.5 Merck
14.3.6 Vetoquinol
14.3.7 Virbac
14.3.8 Dechra Pharmaceuticals
14.3.9 Ceva Sante Animale
14.3.10 Aratana Therapeutics
